These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 23201642)

  • 1. Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities.
    Ndinguri MW; Bhowmick M; Tokmina-Roszyk D; Robichaud TK; Fields GB
    Molecules; 2012 Nov; 17(12):14230-48. PubMed ID: 23201642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New strategies for targeting matrix metalloproteinases.
    Fields GB
    Matrix Biol; 2015; 44-46():239-46. PubMed ID: 25595836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.
    Bhowmick M; Stawikowska R; Tokmina-Roszyk D; Fields GB
    Chembiochem; 2015 May; 16(7):1084-92. PubMed ID: 25766890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases.
    Fields GB
    Front Immunol; 2019; 10():1278. PubMed ID: 31214203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the binding of inhibitors of matrix metalloproteinases by molecular docking, quantum mechanical calculations, molecular dynamics simulations, and a MMGBSA/MMBappl study.
    Singh T; Adekoya OA; Jayaram B
    Mol Biosyst; 2015 Apr; 11(4):1041-51. PubMed ID: 25611160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases: fold and function of their catalytic domains.
    Tallant C; Marrero A; Gomis-Rüth FX
    Biochim Biophys Acta; 2010 Jan; 1803(1):20-8. PubMed ID: 19374923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validating the 1,2-Difluoro Motif As a Hybrid Bioisostere of CF
    Erdeljac N; Thiehoff C; Jumde RP; Daniliuc CG; Höppner S; Faust A; Hirsch AKH; Gilmour R
    J Med Chem; 2020 Jun; 63(11):6225-6237. PubMed ID: 32379447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of tropoelastin peptide-based inhibitors of metalloproteinases.
    Jensen SA; Andersen P; Vrhovski B; Weiss AS
    Arch Biochem Biophys; 2003 Jan; 409(2):335-40. PubMed ID: 12504900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
    Li W; Saji S; Sato F; Noda M; Toi M
    Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.
    Abdel-Hamid NM; Abass SA
    Mol Biol Rep; 2021 Sep; 48(9):6525-6538. PubMed ID: 34379286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
    Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
    Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synergy between the catalytic and structural Zn(II) ions and the enzyme and substrate dynamics underlies the structure-function relationships of matrix metalloproteinase collagenolysis.
    Varghese A; Chaturvedi SS; Fields GB; Karabencheva-Christova TG
    J Biol Inorg Chem; 2021 Aug; 26(5):583-597. PubMed ID: 34228191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
    Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P
    Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites.
    Overall CM
    Mol Biotechnol; 2002 Sep; 22(1):51-86. PubMed ID: 12353914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.
    Lauer-Fields JL; Minond D; Chase PS; Baillargeon PE; Saldanha SA; Stawikowska R; Hodder P; Fields GB
    Bioorg Med Chem; 2009 Feb; 17(3):990-1005. PubMed ID: 18358729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
    Shoari A; Rasaee MJ; Kanavi MR; Daraei B
    J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Broad-Spectrum MMP Inhibitors by Virtual Screening.
    Gimeno A; Cuffaro D; Nuti E; Ojeda-Montes MJ; Beltrán-Debón R; Mulero M; Rossello A; Pujadas G; Garcia-Vallvé S
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting MMP P
    Tokmina-Roszyk M; Fields GB
    J Biol Chem; 2018 Oct; 293(43):16661-16676. PubMed ID: 30185620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
    Jani M; Tordai H; Trexler M; Bányai L; Patthy L
    Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents.
    Xie XW; Wan RZ; Liu ZP
    ChemMedChem; 2017 Aug; 12(15):1157-1168. PubMed ID: 28722301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.